Back to Journals » Neuropsychiatric Disease and Treatment » Volume 17 » Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain
Please verify you are not a robot.